Insertion/deletion polymorphism in intron 16 of the ACE gene and left ventricular hypertrophy in patients with end-stage renal disease
References (0)
Cited by (34)
Genetics of heart failure
2013, Biochimica et Biophysica Acta - Molecular Basis of DiseaseCitation Excerpt :The most reproducible finding regarding this polymorphism is the association between DD genotype and the progression of ischaemic or nonischaemic heart failure, with decreased transplant-free survival [34–38]. Some studies have also shown that patients with the DD genotype have the greatest benefit from ACE inhibitor and beta-blocker therapy [37,38] as well as a relationship between the DD genotype and left ventricular hypertrophy (LVH) [39–47]. Nevertheless, these case–control studies are characterised by small and heterogeneous samples.
Renal Function Dependent Association of AGTR1 Polymorphism (A1166C) and Electrocardiographic Left-Ventricular Hypertrophy
2007, American Journal of HypertensionCitation Excerpt :In a small sample of the general population, the DD genotype was associated with LVH.26 In end-stage renal disease, the ACE I/D polymorphism was either found to be neutral regarding LVH,22,27 or to be a risk factor for LVH,28 but these studies were limited by small sample size. In our study, the ACE I/D polymorphism was neutral, but renal function influenced the association with LVH.
Cardiovascular disease in end-stage renal disease
2006, Hong Kong Journal of NephrologyACE I/D polymorphism is associated with mortality in a cohort study of patients starting with dialysis
2005, Kidney InternationalAmerican Journal of Kidney Diseases: Foreword
2005, American Journal of Kidney DiseasesACE gene polymorphism, left ventricular geometry, and mortality in diabetic patients with end-stage renal disease
2004, Diabetes Research and Clinical Practice